<?xml version="1.0" encoding="UTF-8"?>
<ref id="B47-vaccines-07-00091">
 <label>47.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Paquette</surname>
    <given-names>S.G.</given-names>
   </name>
   <name>
    <surname>Banner</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Zhao</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Fang</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Huang</surname>
    <given-names>S.S.</given-names>
   </name>
   <name>
    <surname>Leomicronn</surname>
    <given-names>A.J.</given-names>
   </name>
   <name>
    <surname>Ng</surname>
    <given-names>D.C.</given-names>
   </name>
   <name>
    <surname>Almansa</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Martin-Loeches</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Ramirez</surname>
    <given-names>P.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Interleukin-6 is a potential biomarker for severe pandemic H1N1 influenza A infection</article-title>
  <source>PLoS ONE</source>
  <year>2012</year>
  <volume>7</volume>
  <elocation-id>e38214</elocation-id>
  <pub-id pub-id-type="doi">10.1371/journal.pone.0038214</pub-id>
  <pub-id pub-id-type="pmid">22679491</pub-id>
 </element-citation>
</ref>
